查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1847185

美國介入性心臟病器材市場：市場規模、佔有率和趨勢分析（2025-2031 年）

Interventional Cardiology Device Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Coronary Stents Coronary Balloon Catheters Balloon-Inflation Devices, and 12 more
出版日期: | 出版商: iData Research Inc. | 英文 271 Pages | 商品交期: 最快1-2個工作天內

價格
如有價格方面的疑問請按下「詢問」鍵來信查詢

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年美國介入性心臟病器材市場規模約44億美元。預計在預測期內，該市場規模將超過56億美元。

本報告對經皮冠狀動脈介入治療及相關診斷檢查中使用的所有核心產品類別進行了規模和分析，包括冠狀動脈支架、冠狀動脈導管導引線導管、球囊擴張裝置、介入冠狀動脈導管、介入冠狀動脈動脈粥狀硬化斑塊切除術、冠狀動脈栓塞保護裝置 (EPD)、冠狀動脈斑塊切除術和血管內碎石術 (IVL) 裝置、導引鞘、冠狀動脈完全超音波(CTO)系統、導管鞘、冠狀動脈血管光同調斷層掃瞄(VCD)、診斷性冠狀動脈導管導引線和導引線、經皮血管內超音波 (IVUS)、冠狀動脈光學相干斷層掃描 (OCT) 和止血產品類型。

量化範圍包括銷量、平均售價、市值、成長率、企業市場占有率和手術例數。

定性內容包括市場促進因素和阻礙因素、併購、投資組合更新以及醫院和導管室的實際技術趨勢。

市場概覽

美國的介入性心臟病學正朝著數據引導、影像豐富和流程高效的方向發展。預計經皮冠狀動脈介入治療（PCI）的數量將以較低的個位數成長率成長，但設備需求不僅受數量驅動，也受產品組合的影響。

醫生利用血管內超音波（IVUS）和光學相干斷層掃描（OCT）來確定血管大小、表徵斑塊並最佳化支架植入。這種以影像為先導的方法正在影響病灶預備工具的選擇，包括經皮冠狀動脈介入治療（PTCA）、特殊球囊、藥物釋放型支架以及用於鈣化病變的斑塊切除術和血管內雷射消融術（動脈粥狀硬化斑塊切除術）。同時，醫療機構正面臨人員短缺、價格壓力和合約整合等問題。

這導致人們對捆綁式佈置、標準化托盤、徑向通道和閉合裝置的興趣日益濃厚，這些措施可以縮短恢復時間並加快房間週轉速度。

在預測期內，影像技術將更深入地融入規劃和決策中，而支架和球囊平台將繼續改進輸送性、外形和塗層技術，以應對更廣泛的病變，並獲得可預測的結果。

市場促進因素

新技術的發展。包括CT、MRI、IVUS和OCT在內的先進心血管影像技術的應用，提高了病變檢出率和手術方案製定的準確性。新一代藥物釋放型支架結構更加精密，藥物塗層更薄，預計將提高療效並擴大可治療的病變類型。

研發投入龐大。患者群體不斷成長，推動了各領域參與度的提升。激烈的競爭加速了導管導引線、微導管、球囊、動脈粥狀硬化斑塊切除術、血管內雷射消融術和封堵器等領域的創新，從而實現了更快、更微創的手術和更穩定的治療效果。

糖尿病盛行率不斷上升。到2021年，美國約有11%的人口患有糖尿病。這種疾病負擔增加了冠狀動脈疾病的盛行率，從而對經皮冠狀動脈介入治療（PCI）的需求持續成長，尤其是在伴隨瀰漫性動脈粥狀硬化和鈣化的複雜病變中。

經皮冠狀動脈介入治療（PCI）手術量。預計PCI手術量將以較低的個位數成長率成長。即使手術量僅略有成長，也會增加對支架、球囊導管、介入導管、導管導引線以及每例手術中使用的相關設備的需求。

影像主導的最佳化。醫療機構投資於血管內超音波（IVUS）主機、光學相干斷層掃描（OCT）平台和成像導管，以減少定位誤差，最佳化支架擴張，並記錄結果，供品質管理專案和支付方使用。

橈動脈入路與術後恢復。橈動脈入路的廣泛應用有助於提高患者舒適度並縮短住院時間。這有利於使用導引器、橈動脈專用鞘套以及專為快速止血和早期下床活動而設計的血管閉合裝置。

病變預備工具。對於複雜的鈣化病變，可採用動脈粥狀硬化斑塊切除術或血管內震波碎石術來改善支架輸送性能，確保支架完全擴張，從而降低血管再阻塞和再次手術的風險。

市場限制

外部市場短缺。技術純熟勞工短缺對供應商和醫療服務提供者都造成了影響。生產延誤、服務週期延長以及導管室人員短缺會降低吞吐量並加劇資本規劃壓力。這些壓力也推動市場朝向自動化和精簡產品選擇方向發展。

捆綁銷售和價格壓力。大型競爭對手透過談判達成涵蓋支架、球囊、導管導引線、導管和椎體閉合裝置等廣泛產品的系統性合約。捆綁銷售簡化了採購流程，但也壓縮了平均售價，給小型製造商帶來了挑戰。隨著行業整合加劇，預計許多產品類別的價格將穩定下降。

冠狀動脈疾病的替代治療方法。除了經皮冠狀動脈介入治療（PCI）之外，患者和臨床醫生還在利用復健計畫、藥物最佳化和個人化自我管理。補充和替代療法、自我檢測以及藥物技術的進步，在某些情況下可能會延緩甚至取代介入治療，這限制了該手術的發展。

影像設備投資。 OCT 和 IVUS 需要前期投資購買主機，並需持續支付耗材費用。一些中心正在分階段實施這些技術，同時評估其使用和報銷模式。

供應鏈和監管摩擦：產品組合更新和合規措施可能會延長產品上市時間，並使庫存更加複雜。

目標市場和數據範圍

定量分析：市場規模、市場佔有率、市場預測、成長率、銷售量、平均售價和手術數量。

定性通報：成長促進因素和阻礙因素、競爭分析、主要競爭對手的 SWOT 分析、併購、公司簡介和產品系列、FDA 召回（如適用）、顛覆性技術、影響 PCI 治療路徑的疾病概況。

時限：基準年 2024 年，預測年 2025-2031 年，歷史資料 2021-2024 年。

資料來源：對行業領袖和醫生的直接訪談、政府醫生和手術資料、監管資料庫、私人醫院資料、進出口資料、iData Research 內部資料庫。

方法論收入模型為單位乘以平均售價，並根據 PCI 量、影像採用率、入院途徑組合以及醫院和綜合醫療服務網路中的設施採購模式檢驗。

目標市場及區隔

冠狀動脈支架市場

器械類型：裸金屬支架、藥物釋放型支架、覆膜支架、分岔支架。

單年單位佔有率依尺寸區隔：直徑和長度。

冠狀動脈球囊導管

器械類型： PTCA球囊擴張術，特殊球囊。

按類別分類的年度銷售量佔有率：合規、半相容、不合規。

以適應症分類的單年銷售佔有率。術前擴張和支架置入，術後擴張。

球囊擴張裝置

冠狀動脈導管

器械類型：引導管、擴張引導管、微導管。

冠狀動脈導管導引線

冠狀動脈栓塞保護裝置（EPD）

冠狀動脈動脈粥狀硬化斑塊切除術裝置

設備類型：機械切除術、雷射切除術、血管內碎石術（IVL）。

冠狀動脈血栓切除術

冠狀動脈慢性完全阻塞（CTO）系統

器械類型： 導管導引線、CTO導管、CTO器械。

導引鞘

器械類型：標準導引器、導引器。

依入路：股骨、橈骨。

冠狀動脈血管閉合裝置（VCD）

侵入性VCD和非侵入性VCD。

診斷性冠狀動脈導管和導管導引線

器械類型：診斷導管、診斷導管導引線、血流儲備分數導管導引線。

冠狀動脈血管內超音波（IVUS）

設備類型： IVUS導管，IVUS主機。

冠狀動脈光同調斷層掃瞄（OCT）

設備類型：OCT導管、OCT主機。

止血瓣

競爭分析

波士頓科學公司在冠狀動脈支架、冠狀動脈球囊導管和冠狀動脈栓塞保護裝置領域佔主導地位，並將成為 2024 年的主要競爭對手。隨著新型冠狀動脈藥物塗層球囊的普及，預計其市場佔有率將穩定成長。

雅培擁有廣泛的產品組合，並在各個區隔市場中均名列前茅。雅培在OCT領域沒有直接競爭對手，這鞏固了其在影像主導PCI策略方面的領先地位。預計該公司將保持其整體市場佔有率。

排名第三的是ShockWave Medical公司，該公司專門從事血管內碎石術（IVL）。 IVL技術近年來才獲得核准，但在治療冠狀動脈鈣化斑塊的應用持續快速成長。

其他參與企業在支架、球囊、導管導引線、導管、血管閉合裝置（VCD）、血栓切除術和診斷影像學等領域競爭。競爭優勢體現在產品組合的深度、橈動脈入路解決方案、在複雜解剖結構中的輸送能力，以及將影​​像引導與病變準備和器械植入相結合的能力。

科技與臨床趨勢

影像學是手術的基礎。血管內超音波（IVUS）和光學相干斷層掃描（OCT）正從選用工具逐漸成為許多實驗室的常規指導手段。醫師依賴影像學評估斑塊形態、鈣化深度和支架擴張情況。高解析度CT在特定病例中可用於術前規劃。

鈣化管理。動脈粥狀硬化斑塊切除術和血管內震波碎石術（IVL）的發展反映了安全、可預測地治療高度鈣化病灶的需求。這些技術提高了支架完全擴張和獲得持久療效的可能性。

更聰明的球囊和支架。具有特定順應性和改進外形的專用球囊，以及先進的藥物釋放型支架，有助於解決複雜的解剖結構和分叉問題，同時控制手術時間。

以橈動脈入路為主導的工作流程。醫療機構投資購買橈動脈導管導入器、微型導管導入器和血管閉合解決方案，以支持合適的患者早期下床活動和當日出院。

實驗室效率。人員短缺迫使實驗室將托盤標準化，最佳化充氣裝置，並選擇能縮短恢復時間的閉合裝置。影像最佳化還能減少重複操作，並支援以價值為導向的目標。

資料和文檔。成像系統和主機支援品質計劃、同行評審和合約的案例文件記錄，從而增強了採用該系統的必要性。

護理機構

本報告針對醫院、綜合醫療服務網路以及學術和區域性導管室。報告涵蓋了直接採購、集團採購安排和供應商管理庫存等採購模式。

設施類型會影響存取方式、影像實施和捆綁合約偏好。

Radial First 工廠將專注於導引器和閉合產品。

病例量大、病情複雜的中心往往會更快地投資於 IVUS 和 OCT，並擁有更廣泛的動脈粥狀動脈粥狀硬化斑塊切除術和 IVL 工具來進行鈣化管理。

地區

本期重點關注美國。

本報告的目的

到 2031 年，美國介入性心臟病學器材市場中最大、成長最快的機會是什麼？支架、球囊、斑塊切除術、血管內雷射消融術 (IVL)、動脈粥狀硬化斑塊切除術(CTO) 系統、導管導引線、導管、心肺復甦術 (EPD)、血管閉合裝置 (VCD)、血管內超音波 (IVUS) 和光學相干斷層掃描 (OCT) 將各自如何創造價值？

介入性心臟病設備市場與美國整體經濟和醫院管理有何關係？包括人員配備限制、診斷影像的資本規劃以及有利於捆綁銷售和標準化的採購策略。

未來哪些因素會影響市場走向，例如血管內超音波 (IVUS) 和光學相干斷層掃描 (OCT) 的發展、藥物釋放型支架的改進以及橈動脈入路和當日出院途徑的普及？

哪一種顯像模式最有利於日常診療中的最佳化？實驗室應如何根據病例組合、報銷情況和工作人員的熟悉程度來決定採用血管內超音波（IVUS）還是光學相干斷層掃描（OCT）？

病變準備策略將如何發展？在治療嚴重鈣化時，動脈粥狀硬化斑塊切除術和血管內震波碎石術（IVL）的適當作用是什麼，以確保完全擴張並減少血管再阻塞？

合規、半相容和不合規的設定檔會對交付率、安全性和一致性產生怎樣的影響？

預計橈動脈入路和股動脈入路之間的平衡如何？這種選擇將如何影響醫院和導管室對導引鞘、導引器、閉合閉合裝置、止血閥和附件包的需求？

具體而言，OCT 和 IVUS 在病變評估、支架尺寸確定和放置後最佳化、主機放置、一次性導管拉出以及培訓需求方面的應用。

鑑於下一代藥物釋放型支架和藥物塗層球囊的安全審查歷史以及它們對更細支架、改性聚合物和可控藥物輸送的重視，它們將如何影響病例選擇和定價？

對於鈣化病變，血管內碎石術的現實軌跡是什麼？在複雜的PCI手術中，血管內碎石術與動脈粥狀硬化斑塊切除術和高壓非順應性球囊的使用有何交互作用？

iData Research 的「美國介入性心臟病設備市場報告」透過區隔和配置模型、企業市場占有率分析、定價詳情以及將成像和接入選擇與設備消費聯繫起來的研究來回答這些問題。

利用這份報告，按類別拓展業務機會，規劃產品藍圖，使合約和庫存與醫院需求保持一致，並設定培訓和服務目標，以提高導管室的一致性。

目錄

圖表清單

圖表列表

美國介入性心臟病器材市場概覽

競爭分析

市場趨勢

市場趨勢

流程分段

待調查的程式碼

市場區隔

重要報告更新

版本歷史記錄

調查方法

全球關稅的影響

美國介入性心臟病器材市場概覽

  • 介紹
    • 處於風險中的族群
  • 市場概況及趨勢分析
  • 推動和阻礙因素
  • 競爭市佔率分析
  • 併購

手術次數

  • 介紹
  • 程式
    • 血管造影術
    • 血管成形術/經皮冠狀動脈介入治療
    • 冠狀動脈切除術
    • 慢性完全冠狀動脈阻塞手術
    • 導管插入術
    • 冠狀動脈血管內超音波
    • 冠狀動脈光學同調斷層掃描
    • 血流儲備分數導管導引線技術

冠狀動脈支架市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 冠狀動脈支架市場整體狀況
    • 裸金屬支架市場
    • 藥物釋放型支架市場
    • 覆蓋支架市場
    • 雙支架市場
  • 單位數量分析
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈球囊導管市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 冠狀動脈球囊導管市場整體狀況
    • Ptca氣球市場
    • 氣球專業市場
    • 冠狀動脈球囊導管裝置（依分類）
    • 冠狀動脈球囊導管裝置（依適應症）
  • 推動和阻礙因素
  • 競爭市佔率分析

氣球充氣裝置市場

  • 介紹
  • 市場分析與預測
  • 推動和阻礙因素
  • 競爭市佔率分析

介入性冠狀動脈導管市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 介入性冠狀動脈導管市場總規模
    • 導尿管市場指南
    • 延長引導管市場
    • 微導管市場
  • 推動和阻礙因素
  • 競爭市佔率分析

介入性冠狀動脈導線市場

  • 介紹
    • 建構設備
  • 市場分析與預測
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈栓塞保護裝置市場

  • 介紹
    • 大隱靜脈移植
    • 保護機制
  • 市場分析與預測
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈粥樣斑塊切除器械市場

  • 介紹
    • 設備技術
  • 市場概覽
  • 市場分析與預測
    • 全冠狀動脈粥樣斑塊切除器械市場
    • 機械動脈切除術市場
    • 雷射動脈切除術市場
    • 血管內碎石市場
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈血栓切除術市場

  • 介紹
    • 藥物釋放型支架及血栓症治療
  • 市場分析與預測
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈慢性完全阻塞系統市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 冠狀動脈慢性完全阻塞系統市場
    • Cto導管導引線市場
    • CTO導管市場
    • CTO設備市場
  • 推動和阻礙因素
  • 競爭市佔率分析

導引鞘市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 導引鞘市場
    • 標準導引鞘市場
    • 導引鞘市場
  • 方法導引鞘單元
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈閉合裝置市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 冠狀動脈封堵器市場整體狀況
    • 競爭激烈的VCD市場
    • 非侵入式VCD市場
  • 推動和阻礙因素
  • 競爭市佔率分析

診斷性冠狀動脈導管和導管導引線市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • 冠狀動脈診斷導管和導管導引線市場總規模
    • 診斷導管市場
    • 診斷導管導引線市場
    • 血流儲備分數導管導引線市場
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈血管內超音波市場

  • 介紹
    • 支架置入前
    • 支架置入術後
    • 靜脈注射
  • 市場概覽
  • 市場分析與預測
    • Ivus導管市場
    • Ivus主機市場
  • 推動和阻礙因素
  • 競爭市佔率分析

冠狀動脈光學同調斷層掃描市場

  • 介紹
  • 市場概覽
  • 市場分析與預測
    • OCT導管市場
    • OCT主機市場
  • 推動和阻礙因素
  • 競爭市佔率分析

止血閥市場

  • 介紹
  • 市場分析與預測
  • 推動和阻礙因素
  • 競爭市佔率分析

簡稱

Product Code: iDATA_USIC25_MS

The U.S. interventional cardiology device market was valued at nearly $4.4 billion in 2024. The market is projected to exceed $5.6 billion over the forecast period.

This report sizes and analyzes all core product categories used in percutaneous coronary intervention and related diagnostic workups, including coronary stents, coronary balloon catheters, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices (EPDs), coronary atherectomy and intravascular lithotripsy (IVL) devices, coronary thrombectomy, coronary chronic total occlusion (CTO) systems, introducer sheaths, coronary vascular closure devices (VCDs), diagnostic coronary catheters and guidewires, coronary intravascular ultrasound (IVUS), coronary optical coherence tomography (OCT), and hemostasis valves.

Quantitative coverage includes unit sales, average selling prices, market values, growth rates, company shares, and procedure numbers.

Qualitative coverage includes market drivers and limiters, mergers and acquisitions, portfolio updates, and practical technology trends across hospitals and cath labs.

Market Overview

Interventional cardiology in the United States continues to evolve toward data-guided, image-rich, and workflow-efficient procedures. PCI volumes are expected to rise at a low single-digit rate, but device demand is shaped more by product mix than by raw volume alone.

Physicians use IVUS and OCT to size vessels, characterize plaque, and optimize stent expansion. This imaging-first approach influences selection of PTCA and specialty balloons, drug-eluting stents, and lesion preparation tools including atherectomy and IVL for calcified disease. At the same time, facilities face staffing constraints, price pressure, and contract consolidation.

These forces drive interest in bundled contracts, standardized trays, radial access, and closure devices that shorten recovery and turn rooms faster.

Over the forecast period, imaging will be more deeply integrated into planning and decision making, while stent and balloon platforms will continue to improve deliverability, profiles, and coating technologies to serve a broader range of lesions with predictable outcomes.

Market Drivers

New technological developments. Adoption of advanced cardiovascular imaging, including CT, MRI, IVUS, and OCT, improves lesion detection and procedural planning. Next-generation drug-eluting stents with refined construction and thinner drug coatings are expected to enhance effectiveness and broaden treatable lesion types.

High rate of research and development. A growing patient population attracts more participants across segments. Competition accelerates innovation in guidewires, micro-catheters, balloons, atherectomy, IVL, and closure devices, leading to faster and less invasive procedures with more consistent results.

Rising rates of diabetes. In 2021, about 11 percent of the U.S. population had diabetes. This disease burden raises the prevalence of coronary artery disease and supports steady PCI demand, particularly in complex lesions associated with diffuse atherosclerosis and calcification.

PCI procedure volume. PCI is projected to grow at a low single-digit rate. Even modest procedural expansion increases demand for stents, balloon catheters, interventional catheters, guidewires, and associated equipment used in each case.

Imaging-led optimization. Facilities invest in IVUS consoles, OCT platforms, and imaging catheters to reduce geographic miss, optimize stent expansion, and document results for quality programs and payers.

Radial access and recovery. Wider use of radial access supports patient comfort and shorter stays. This favors micro-introducers, radial-specific sheaths, and closure devices tailored to rapid hemostasis and early ambulation.

Lesion preparation tools. Complex calcified lesions drive use of atherectomy and IVL to improve deliverability and ensure full stent expansion, which reduces restenosis risk and repeat procedures.

Market Limiters

External market shortages. Skilled labor shortages affect both suppliers and providers. Production delays, longer service cycles, and staffing gaps in cath labs slow throughput and weight capital planning. These pressures also push the market toward automation and streamlined product choices.

Bundling and price pressure. Large competitors use broad portfolios to negotiate system-wide contracts covering stents, balloons, guidewires, catheters, and VCDs. Bundling simplifies procurement but compresses ASPs and challenges smaller manufacturers. As consolidation continues, steady price declines are expected in many categories.

Alternative treatment methods for CAD. Beyond PCI, patients and clinicians use rehab programs, medical therapy optimization, and personal self-management. Complementary and alternative approaches, self-testing, and drug advances can delay or substitute for interventions in some cases, dampening procedural growth.

Capital diligence for imaging. OCT and IVUS require upfront console investment and ongoing disposable costs. Some centers phase adoption while they evaluate utilization and reimbursement patterns.

Supply chain and regulatory friction. Portfolio refreshes and compliance steps can lengthen launch timelines and complicate inventory.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, average selling prices, and procedure numbers.

Qualitative coverage. Growth drivers and limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where applicable, disruptive technologies, and disease overviews that influence PCI care pathways.

Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2024.

Data sources. Primary interviews with industry leaders and physicians, government physician and procedure data, regulatory databases, hospital private data, import and export data, and the iData Research internal database.

Method note. Revenue is modeled from units multiplied by ASP and validated against PCI volumes, imaging adoption, access approach mix, and facility purchasing patterns across hospitals and integrated delivery networks.

Markets Covered and Segmentation

Coronary Stent Market

Device type. Bare-metal stent, drug-eluting stent, covered stent, bifurcated stent.

Single-year unit share breakdown by size. Diameter and length.

Coronary Balloon Catheter

Device type. PTCA balloon and specialty balloon.

Single-year unit share by classification. Compliant, semi-compliant, non-compliant.

Single-year unit share by indication. Pre-dilation and stent placement, post-dilation.

Balloon-Inflation Device

Interventional Coronary Catheter

Device type. Guiding catheter, extension guide catheter, micro-catheter.

Interventional Coronary Guidewire

Coronary Embolic Protection Device (EPD)

Coronary Atherectomy Device

Device type. Mechanical atherectomy, laser atherectomy, intravascular lithotripsy (IVL).

Coronary Thrombectomy

Coronary Chronic Total Occlusion (CTO) System

Device type. CTO guidewire, CTO catheter, CTO device.

Introducer Sheath

Device type. Standard introducer, micro-introducer.

By approach. Femoral, radial.

Coronary Vascular Closure Device (VCD)

Invasive VCD and non-invasive VCD.

Diagnostic Coronary Catheter and Guidewire

Device type. Diagnostic catheter, diagnostic guidewire, fractional flow reserve guidewire.

Coronary Intravascular Ultrasound (IVUS)

Device type. IVUS catheter, IVUS console.

Coronary Optical Coherence Tomography (OCT)

Device type. OCT catheter, OCT console.

Hemostasis Valve

Competitive Analysis

Boston Scientific was the leading competitor in 2024 with dominant positions in coronary stents, coronary balloon catheters, and coronary embolic protection devices. A new coronary drug-coated balloon is expected to support modest share expansion as adoption develops.

Abbott ranked second with a broad portfolio and frequent top positions across device categories. Abbott faces no direct competition in the OCT segment, which supports its standing across imaging-driven PCI strategies. The company is expected to maintain overall share.

ShockWave Medical ranked third and specializes in intravascular lithotripsy (IVL). IVL has been approved only in recent years but continues to expand quickly due to its ability to address calcified plaque in coronary vessels.

Other participants compete in selected stents, balloons, guidewires, catheters, VCDs, thrombectomy, and imaging. Competitive advantage reflects portfolio depth, radial access solutions, deliverability in tortuous anatomy, and the ability to tie imaging guidance to lesion preparation and device deployment.

Technology and Practice Trends

Imaging becomes procedural fabric. IVUS and OCT move from optional tools to routine guidance in many labs. Physicians rely on imaging to assess plaque morphology, calcification depth, and stent expansion. High-resolution CT supports pre-procedural planning in selected cases.

Calcium management. Growth in atherectomy and IVL reflects the need to treat heavily calcified lesions safely and predictably. These tools increase the likelihood of full stent expansion and durable outcomes.

Smarter balloons and stents. Specialty balloons with defined compliance and improved profiles, along with refined drug-eluting stents, help address complex anatomies and bifurcations while keeping procedure time under control.

Radial-first workflow. Facilities invest in radial introducers, micro-introducers, and closure solutions that support early ambulation and same-day discharge in appropriate patients.

Room efficiency. Staffing shortages push labs to standardize trays, streamline inflation devices, and select closure devices that reduce recovery time. Imaging-driven optimization also reduces repeat procedures and supports value-based targets.

Data and documentation. Imaging systems and consoles support case documentation for quality programs, peer review, and contracting, which strengthens the capital case for adoption.

Care Settings

Coverage includes hospitals, integrated delivery networks, and cath labs in academic and community settings. The report addresses procurement models that use direct purchase and group purchasing contracts, along with vendor-managed inventory where used.

Facility type influences access approach, imaging adoption, and preferences for bundled contracts.

Radial-first centers emphasize micro-introducers and closure products.

High-volume centers with complex case mix tend to invest earlier in IVUS and OCT and carry a wider range of atherectomy and IVL tools for calcium management.

Geography

This edition covers the United States.

Why This Report

Where is the largest and fastest growing opportunity within the U.S. interventional cardiology device market and how do stents, balloons, atherectomy, IVL, CTO systems, guidewires, catheters, EPDs, VCDs, IVUS, and OCT each contribute to value through 2031.

How does the interventional cardiology device market relate to the broader U.S. economy and hospital operations, including staffing constraints, capital planning for imaging, and purchasing strategies that favor bundles and standardization.

What forces will shape the market going forward, including growth in IVUS and OCT, refinement of drug-eluting stents, and the spread of radial access and same-day discharge pathways.

Which imaging modalities best support optimization in daily practice, and how should labs decide between IVUS and OCT based on case mix, reimbursement, and staff proficiency.

How will lesion preparation strategies evolve, and what is the right role for atherectomy versus IVL when treating severe calcification to ensure full expansion and reduce restenosis.

What mix of balloons is most effective across pre-dilation and post-dilation, and how do compliant, semi-compliant, and non-compliant profiles affect deliverability, safety, and consistency.

What is the expected balance between radial and femoral access, and how will this choice change demand for introducer sheaths, micro-introducers, closure devices, hemostasis valves, and accessory kits across hospitals and cath labs.

How will imaging choices evolve, in particular the adoption of OCT versus IVUS for lesion assessment, stent sizing, and post-deployment optimization, and what does this mean for console placements, disposable catheter pull-through, and training needs.

How will the next generation of drug-eluting stents and drug-coated balloons affect case selection and pricing, given the history of safety reviews and the emphasis on thinner struts, polymer changes, and controlled drug delivery.

What is the realistic trajectory for intravascular lithotripsy in calcified lesions, and how will IVL usage interact with atherectomy and high-pressure non-compliant balloons in complex PCI.

The U.S. interventional cardiology device market report from iData Research answers these questions with segment and setting models, company share analysis, pricing detail, and coverage that links imaging and access choices to device consumption.

Use it to size opportunities by category, plan product roadmaps, align contracting and inventory with hospital needs, and set targets for training and service that improve consistency across cath labs.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

U.S. Interventional Cardiology Device Market Overview

Competitive Analysis

Market Developments

Market Trends

Procedure Segmentation

Procedure Codes Investigated

Market Segmentation

Key Report Updates

Version History

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

U.S. Interventional Cardiology Device Market Overview

  • 3.1 Introduction
    • 3.1.1 Population At Risk
  • 3.2 Market Overview & Trend Analysis
  • 3.3 Drivers And Limiters
    • 3.3.1 Market Drivers
    • 3.3.2 Market Limiters
  • 3.4 Competitive Market Share Analysis
  • 3.5 Mergers And Acquisitions

Procedure Numbers

  • 4.1 Introduction
  • 4.2 Procedures
    • 4.2.1 Angiography Procedures
    • 4.2.2 Angioplasty/ Pci Procedures
    • 4.2.3 Coronary Atherectomy Procedures
    • 4.2.4 Coronary Chronic Total Occlusion Procedures
    • 4.2.5 Catheterization Procedures
    • 4.2.6 Coronary Intravascular Ultrasound Procedures
    • 4.2.7 Coronary Optical Coherence Tomography Procedures
    • 4.2.8 Fractional Flow Reserve Guidewire Procedures

Coronary Stent Market

  • 5.1 Introduction
  • 5.2 Market Overview
  • 5.3 Market Analysis And Forecast
    • 5.3.1 Total Coronary Stent Market
    • 5.3.2 Bare-Metal Stent Market
    • 5.3.3 Drug-Eluting Stent Market
    • 5.3.4 Covered Stent Market
    • 5.3.5 Bifurcated Stent Market
  • 5.4 Unit Analysis
    • 5.4.1 Coronary Stent Units Sold By Diameter
    • 5.4.2 Coronary Stent Units Sold By Length
  • 5.5 Drivers And Limiters
    • 5.5.1 Market Drivers
    • 5.5.2 Market Limiters
  • 5.6 Competitive Market Share Analysis

Coronary Balloon Catheter Market

  • 6.1 Introduction
  • 6.2 Market Overview
  • 6.3 Market Analysis And Forecast
    • 6.3.1 Total Coronary Balloon Catheter Market
    • 6.3.2 Ptca Balloon Market
    • 6.3.3 Specialty Balloon Market
      • 6.3.3.1 Cutting Balloon Market
      • 6.3.3.2 Scoring Balloon Market
      • 6.3.3.3 Drug-Coated Balloon Market
    • 6.3.4 Coronary Balloon Catheter Units By Classification
    • 6.3.5 Coronary Balloon Catheter Units By Indication
  • 6.4 Drivers And Limiters
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 Competitive Market Share Analysis

Balloon-Inflation Device Market

  • 7.1 Introduction
  • 7.2 Market Analysis And Forecast
  • 7.3 Drivers And Limiters
    • 7.3.1 Market Drivers
    • 7.3.2 Market Limiters
  • 7.4 Competitive Market Share Analysis

Interventional Coronary Catheter Market

  • 8.1 Introduction
  • 8.2 Market Overview
  • 8.3 Market Analysis And Forecast
    • 8.3.1 Total Interventional Coronary Catheter Market
    • 8.3.2 Guiding Catheter Market
    • 8.3.3 Extension Guide Catheter Market
    • 8.3.4 Micro-Catheter Market
      • 8.3.4.1 Traditional Coronary Microcatheter Market
      • 8.3.4.1.1 Torqueable Traditional Coronary Microcatheter Market
      • 8.3.4.1.2 Braided Traditional Coronary Microcatheter Market
      • 8.3.4.2 Dual Lumen Specialty Coronary Microcatheter Market
  • 8.4 Drivers And Limiters
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 Competitive Market Share Analysis

Interventional Coronary Guidewire Market

  • 9.1 Introduction
    • 9.1.1 Device Construction
  • 9.2 Market Analysis And Forecast
  • 9.3 Drivers And Limiters
    • 9.3.1 Market Drivers
    • 9.3.2 Market Limiters
  • 9.4 Competitive Market Share Analysis

Coronary Embolic Protection Device Market

  • 10.1 Introduction
    • 10.1.1 Saphenous Vein Grafts
    • 10.1.2 Protection Mechanism
      • 10.1.2.1 Filter Basket
      • 10.1.2.2 Distal Balloon Occlusion
  • 10.2 Market Analysis And Forecast
  • 10.3 Drivers And Limiters
    • 10.3.1 Market Drivers
    • 10.3.2 Market Limiters
  • 10.4 Competitive Market Share Analysis

Coronary Atherectomy Device Market

  • 11.1 Introduction
    • 11.1.1 Device Technologies
      • 11.1.1.1 Mechanical Atherectomy
      • 11.1.1.2 Laser Atherectomy
      • 11.1.1.3 Directional Coronary Atherectomy (Dca)
      • 11.1.1.4 Intravascular Lithotripsy
  • 11.2 Market Overview
  • 11.3 Market Analysis And Forecast
    • 11.3.1 Total Coronary Atherectomy Device Market
    • 11.3.2 Mechanical Atherectomy Market
    • 11.3.3 Laser Atherectomy Market
    • 11.3.4 Intravascular Lithotripsy Market
  • 11.4 Drivers And Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Coronary Thrombectomy Market

  • 12.1 Introduction
    • 12.1.1 Drug-Eluting Stents And Thrombosis Treatment
  • 12.2 Market Analysis And Forecast
  • 12.3 Drivers And Limiters
    • 12.3.1 Market Drivers
    • 12.3.2 Market Limiters
  • 12.4 Competitive Market Share Analysis

Coronary Chronic Total Occlusion System Market

  • 13.1 Introduction
  • 13.2 Market Overview
  • 13.3 Market Analysis And Forecast
    • 13.3.1 Total Coronary Chronic Total Occlusion System Market
    • 13.3.2 Cto Guidewire Market
    • 13.3.3 Cto Catheter Market
    • 13.3.4 Cto Device Market
  • 13.4 Drivers And Limiters
    • 13.4.1 Market Drivers
    • 13.4.2 Market Limiters
  • 13.5 Competitive Market Share Analysis

Introducer Sheath Market

  • 14.1 Introduction
  • 14.2 Market Overview
  • 14.3 Market Analysis And Forecast
    • 14.3.1 Total Introducer Sheath Market
    • 14.3.2 Standard Introducer Sheath Market
    • 14.3.3 Micro-Introducer Sheath Market
  • 14.4 Introducer Sheath Units By Approach
  • 14.5 Drivers And Limiters
    • 14.5.1 Market Drivers
    • 14.5.2 Market Limiters
  • 14.6 Competitive Market Share Analysis

Coronary Vascular Closure Device Market

  • 15.1 Introduction
  • 15.2 Market Overview
  • 15.3 Market Analysis And Forecast
    • 15.3.1 Total Coronary Vascular Closure Device Market
    • 15.3.2 Invasive Vcd Market
    • 15.3.3 Non-Invasive Vcd Market
      • 15.3.3.1 Topical Hemostat Market
      • 15.3.3.2 Radial Compression Band Market
      • 15.3.3.3 Femoral Compression Band Market
  • 15.4 Drivers And Limiters
    • 15.4.1 Market Drivers
    • 15.4.2 Market Limiters
  • 15.5 Competitive Market Share Analysis

Diagnostic Coronary Catheter & Guidewire Market

  • 16.1 Introduction
  • 16.2 Market Overview
  • 16.3 Market Analysis And Forecast
    • 16.3.1 Total Diagnostic Coronary Catheter & Guidewire Market
    • 16.3.2 Diagnostic Catheter Market
    • 16.3.3 Diagnostic Guidewire Market
    • 16.3.4 Fractional Flow Reserve Guidewire Market
  • 16.4 Drivers And Limiters
    • 16.4.1 Market Drivers
    • 16.4.2 Market Limiters
  • 16.5 Competitive Market Share Analysis

Coronary Intravascular Ultrasound Market

  • 17.1 Introduction
    • 17.1.1 Pre-Stenting Applications
    • 17.1.2 Post-Stenting Applications
    • 17.1.3 Ivus Penetration
  • 17.2 Market Overview
  • 17.3 Market Analysis And Forecast
    • 17.3.1 Ivus Catheter Market
    • 17.3.2 Ivus Console Market
  • 17.4 Drivers And Limiters
    • 17.4.1 Market Drivers
    • 17.4.2 Market Limiters
  • 17.5 Competitive Market Share Analysis

Coronary Optical Coherency Tomography Market

  • 18.1 Introduction
  • 18.2 Market Overview
  • 18.3 Market Analysis And Forecast
    • 18.3.1 Oct Catheter Market
    • 18.3.2 Oct Console Market
  • 18.4 Drivers And Limiters
    • 18.4.1 Market Drivers
    • 18.4.2 Market Limiters
  • 18.5 Competitive Market Share Analysis

Hemostasis Valve Market

  • 19.1 Introduction
  • 19.2 Market Analysis And Forecast
  • 19.3 Drivers And Limiters
    • 19.3.1 Market Drivers
    • 19.3.2 Market Limiters
  • 19.4 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Interventional Cardiology Device Market by Segment, U.S., 2024 - 2031. 2
  • Chart 1-2: Interventional Cardiology Device Market Overview, U.S., 2024 & 2031. 2
  • Chart 3-1: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031. 42
  • Chart 3-2: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024. 53
  • Chart 4-1: Interventional Cardiology Procedures by Segment, U.S., 2021 - 2031. 59
  • Chart 5-1: Coronary Stent Market by Segment, U.S., 2021 - 2031. 78
  • Chart 5-2: Leading Competitors, Coronary Stent Market, U.S., 2024. 91
  • Chart 6-1: Coronary Balloon Catheter Market by Segment, U.S., 2021 - 2031. 95
  • Chart 6-2: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2024. 110
  • Chart 7-1: Balloon-Inflation Device Market, U.S., 2021 - 2031. 113
  • Chart 7-2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2024. 119
  • Chart 8-1: Interventional Coronary Catheter Market by Segment, U.S., 2021 - 2031. 122
  • Chart 8-2: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2024. 138
  • Chart 9-1: Interventional Coronary Guidewire Market, U.S., 2021 - 2031. 141
  • Chart 9-2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2024. 147
  • Chart 10-1: Coronary Embolic Protection Device Market, U.S., 2021 - 2031. 151
  • Chart 10-2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2024. 156
  • Chart 11-1: Coronary Atherectomy Device Market by Segment, U.S., 2021 - 2031. 160
  • Chart 11-2: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2024. 169
  • Chart 12-1: Coronary Thrombectomy Market, U.S., 2021 - 2031. 173
  • Chart 12-2: Leading Competitors, Coronary Thrombectomy Market, U.S., 2024. 178
  • Chart 13-1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2021 - 2031. 182
  • Chart 13-2: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2024. 191
  • Chart 14-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031. 194
  • Chart 14-2: Leading Competitors, Introducer Sheath Market, U.S., 2024. 205
  • Chart 15-1: Coronary Vascular Closure Device Market by Segment, U.S., 2021 - 2031. 209
  • Chart 15-2: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2024. 223
  • Chart 16-1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2021 - 2031. 226
  • Chart 16-2: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2024. 236
  • Chart 17-1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2021 - 2031. 240
  • Chart 17-2: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2024. 248
  • Chart 18-1: Coronary Optical Coherency Tomography Market by Segment, U.S., 2021 - 2031. 252
  • Chart 18-2: Leading Competitors, Coronary Optical Coherency Tomography Market, U.S., 2024. 260
  • Chart 19-1: Hemostasis Valve Market, U.S., 2021 - 2031. 263
  • Chart 19-2: Leading Competitors, Hemostasis Valve Market, U.S., 2024 268

LIST OF FIGURES

  • Figure 1-1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (1 of 3). 3
  • Figure 1-2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (2 of 3). 4
  • Figure 1-3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (3 of 3). 4
  • Figure 1-4: Companies Researched in This Report. 5
  • Figure 1-5: Recent Events in the Interventional Cardiology Device Market, U.S., 2021 - 2025 (1 of 2). 7
  • Figure 1-6: Recent Events in the Interventional Cardiology Device Market, U.S., 2021 - 2025 (2 of 2). 8
  • Figure 1-7: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (1 of 3). 9
  • Figure 1-8: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (2 of 3). 10
  • Figure 1-9: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (3 of 3). 11
  • Figure 1-10: Interventional Cardiology Device Procedure Segmentation (1 of 2). 12
  • Figure 1-11: Interventional Cardiology Device Procedure Segmentation (2 of 2). 13
  • Figure 1-12: Procedure Codes Investigated. 14
  • Figure 1-13: Interventional Cardiology Device Market Segmentation (1 of 3). 15
  • Figure 1-14: Interventional Cardiology Device Market Segmentation (2 of 3). 16
  • Figure 1-15: Interventional Cardiology Device Market Segmentation (3 of 3). 17
  • Figure 1-16: Key Report Updates. 18
  • Figure 1-17: Version History. 19
  • Figure 3-1: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 3). 39
  • Figure 3-2: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 3). 40
  • Figure 3-3: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (3 of 3). 41
  • Figure 3-4: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (1 of 3). 50
  • Figure 3-5: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (2 of 3). 51
  • Figure 3-6: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (3 of 3). 52
  • Figure 4-1: Procedure Codes Investigated, U.S., 2024. 56
  • Figure 4-2: Interventional Cardiology Device Procedures by Segment, U.S., 2021 - 2031 (1 of 2). 57
  • Figure 4-3: Interventional Cardiology Device Procedures by Segment, U.S., 2021 - 2031 (2 of 2). 58
  • Figure 4-4: Angiography Procedures by Devices Used, U.S., 2021 - 2031. 60
  • Figure 4-5: Angiography Procedures by Approach, U.S., 2021 - 2031. 61
  • Figure 4-6: Angiography Procedures by Setting, U.S., 2021 - 2031. 61
  • Figure 4-7: Angioplasty Procedures by Approach, U.S., 2021 - 2031. 62
  • Figure 4-8: Angioplasty Procedures by Modality, U.S., 2021 - 2031. 63
  • Figure 4-9: Angioplasty Procedures by Setting, U.S., 2021 - 2031. 63
  • Figure 4-10: Atherectomy Procedures by Segment, U.S., 2021 - 2031. 65
  • Figure 4-11: Atherectomy Procedures by Setting, U.S., 2021 - 2031. 66
  • Figure 4-12: CTO Procedures by Setting, U.S., 2021 - 2031. 68
  • Figure 4-13: Catheterization Procedures by Setting, U.S., 2021 - 2031. 70
  • Figure 4-14: IVUS Procedures by Segment, U.S., 2021 - 2031. 71
  • Figure 4-15: OCT Procedures by Segment, U.S., 2021 - 2031. 72
  • Figure 4-16: FFR Procedures by Segment, U.S., 2021 - 2031. 73
  • Figure 5-1: Coronary Market by Segment, U.S., 2021 - 2031 (US$M). 77
  • Figure 5-2: Total Coronary Stent Market, U.S., 2021 - 2031. 79
  • Figure 5-3: Bare-Metal Stent Market, U.S., 2021 - 2031. 80
  • Figure 5-4: Drug-Eluting Stent Market, U.S., 2021 - 2031. 81
  • Figure 5-5: Covered Stent Market, U.S., 2021 - 2031. 82
  • Figure 5-6: Bifurcated Stent Market, U.S., 2021 - 2031. 83
  • Figure 5-7: Percent of Coronary Stent Units Sold by Diameter, U.S., 2024. 84
  • Figure 5-8: Percent of Coronary Stent Units Sold by Diameter, U.S., 2024. 85
  • Figure 5-9: Leading Competitors, Coronary Stent Market, U.S., 2024. 90
  • Figure 6-1: Coronary Balloon Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 94
  • Figure 6-2: Total Coronary Balloon Catheter Market, U.S., 2021 - 2031. 96
  • Figure 6-3: PTCA Balloon Market, U.S., 2021 - 2031. 97
  • Figure 6-4: Specialty Balloon Market by Segment, U.S., 2021 - 2031 (US$M). 99
  • Figure 6-5: Total Specialty Balloon Catheter Market, U.S., 2021 - 2031. 99
  • Figure 6-6: Cutting Balloon Market, U.S., 2021 - 2031. 100
  • Figure 6-7: Scoring Balloon Market, U.S., 2021 - 2031. 101
  • Figure 6-8: Drug-Coated Balloon Market, U.S., 2021 - 2031. 102
  • Figure 6-9: Coronary Balloon Catheter Units by Classification, U.S., 2024. 103
  • Figure 6-10: Coronary Balloon Catheter Units by Classification, U.S., 2024. 104
  • Figure 6-11: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2024. 109
  • Figure 7-1: Balloon-Inflation Device Market, U.S., 2021 - 2031. 112
  • Figure 7-2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2024. 118
  • Figure 8-1: Interventional Coronary Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 121
  • Figure 8-2: Total Interventional Coronary Catheter Market, U.S., 2021 - 2031. 123
  • Figure 8-3: Guiding Catheter Market, U.S., 2021 - 2031. 124
  • Figure 8-4: Extension Guide Catheter Market, U.S., 2021 - 2031. 125
  • Figure 8-5: Micro-Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 126
  • Figure 8-6: Total Micro-Catheter Market, U.S., 2021 - 2031. 127
  • Figure 8-7: Traditional Coronary Microcatheter Market by Segment, U.S., 2021 - 2031 (US$M). 128
  • Figure 8-8: Total Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 129
  • Figure 8-9: Torqueable Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 130
  • Figure 8-10: Braided Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 131
  • Figure 8-11: Dual Lumen Specialty Coronary Microcatheter Market, U.S., 2021 - 2031. 132
  • Figure 8-12: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2024. 137
  • Figure 9-1: Interventional Coronary Guidewire Market, U.S., 2021 - 2031. 140
  • Figure 9-2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2024. 146
  • Figure 10-1: Coronary Embolic Protection Device Market, U.S., 2021 - 2031. 150
  • Figure 10-2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2024. 155
  • Figure 11-1: Coronary Atherectomy Device Market by Segment, U.S., 2021 - 2031 (US$M). 159
  • Figure 11-2: Total Coronary Atherectomy Device Market, U.S., 2021 - 2031. 161
  • Figure 11-3: Mechanical Atherectomy Market, U.S., 2021 - 2031. 162
  • Figure 11-4: Laser Atherectomy Market, U.S., 2021 - 2031. 163
  • Figure 11-5: Intravascular Lithotripsy Market, U.S., 2021 - 2031. 164
  • Figure 11-6: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2024. 168
  • Figure 12-1: Coronary Thrombectomy Market, U.S., 2021 - 2031. 172
  • Figure 12-2: Leading Competitors, Coronary Thrombectomy Market, U.S., 2024. 177
  • Figure 13-1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2021 - 2031 (US$M). 181
  • Figure 13-2: Total Coronary Chronic Total Occlusion System Market, U.S., 2021 - 2031. 183
  • Figure 13-3: CTO Guidewire Market, U.S., 2021 - 2031. 184
  • Figure 13-4: CTO Catheter Market, U.S., 2021 - 2031. 185
  • Figure 13-5: CTO Device Market, U.S., 2021 - 2031. 186
  • Figure 13-6: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2024. 190
  • Figure 14-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031 (US$M). 193
  • Figure 14-2: Total Introducer Sheath Market, U.S., 2021 - 2031. 195
  • Figure 14-3: Standard Introducer Sheath Market, U.S., 2021 - 2031. 196
  • Figure 14-4: Micro-Introducer Sheath Market, U.S., 2021 - 2031. 197
  • Figure 14-5: Introducer Sheath Units, by Approach, U.S., 2021 - 2031. 198
  • Figure 14-6: Leading Competitors, Introducer Sheath Market, U.S., 2024. 204
  • Figure 15-1: Coronary Vascular Closure Device Market by Segment, U.S., 2021 - 2031 (US$M). 208
  • Figure 15-2: Total Coronary Vascular Closure Device Market, U.S., 2021 - 2031. 211
  • Figure 15-3: Invasive VCD Market, U.S., 2021 - 2031. 212
  • Figure 15-4: Non-Invasive VCD Market by Segment, U.S., 2021 - 2031 (US$M). 213
  • Figure 15-5: Total Non-Invasive VCD Market, U.S., 2021 - 2031. 214
  • Figure 15-6: Topical Hemostat Market, U.S., 2021 - 2031. 215
  • Figure 15-7: Radial Compression Band Market, U.S., 2021 - 2031. 216
  • Figure 15-8: Femoral Compression Band Market, U.S., 2021 - 2031. 217
  • Figure 15-9: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2024. 222
  • Figure 16-1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2021 - 2031 (US$M). 225
  • Figure 16-2: Total Diagnostic Coronary Catheter & Guidewire Market, U.S., 2021 - 2031. 227
  • Figure 16-3: Diagnostic Catheter Market, U.S., 2021 - 2031. 228
  • Figure 16-4: Diagnostic Guidewire Market, U.S., 2021 - 2031. 229
  • Figure 16-5: Fractional Flow Reserve Guidewire Market, U.S., 2021 - 2031. 230
  • Figure 16-6: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2024. 235
  • Figure 17-1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2021 - 2031 (US$M). 239
  • Figure 17-2: IVUS Catheter Market, U.S., 2021 - 2031. 242
  • Figure 17-3: IVUS Console Market, U.S., 2021 - 2031. 243
  • Figure 17-4: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2024. 247
  • Figure 18-1: Coronary Optical Coherency Tomography Market by Segment, U.S., 2021 - 2031 (US$M). 251
  • Figure 18-2: OCT Catheter Market, U.S., 2021 - 2031. 253
  • Figure 18-3: OCT Console Market, U.S., 2021 - 2031. 254
  • Figure 18-4: Leading Competitors, Coronary Optical Coherency Tomography Market, U.S., 2024. 259
  • Figure 19-1: Hemostasis Valve Market, U.S., 2021 - 2031. 262
  • Figure 19-2: Leading Competitors, Hemostasis Valve Market, U.S., 2024. 267